Evidence map›Paper›PMID 31426594›Full record

ArticleMolecules (Basel, Switzerland)2019

Study on the Material Basis of Neuroprotection of

Shengnan Shen, Mengjun Zhao, Chenchen Li, Qi Chang, Xinmin Liu, Yonghong Liao, Ruile Pan

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Valorization of Bayberry (Plants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Phytochemicals with Added Value fromMolecules (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shengnan ShenInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China.
Mengjun ZhaoInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China.
Chenchen LiInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China.
Qi ChangInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China.
Xinmin LiuInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China.
Yonghong LiaoInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China.
Ruile PanInstitute of Medicinal Plant Development, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100193, China. rlpan@implad.ac.cn.
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

National Mega-project for Innovative Drug 2017ZX09305008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsApoptosisDiarylheptanoidsEnzyme ActivationFlavonoidsHumansMedicine, Chinese TraditionalMyricaNeuroprotective AgentsOxidative StressPC12 CellsPlant BarkPlant ExtractsPlants, MedicinalRatsReactive Oxygen SpeciesDiarylheptanoidsFlavonoidsmyricanol 11-sulfatemyricitrinNeuroprotective AgentsPlant ExtractsReactive Oxygen SpeciesSulfuric Acid EstersSuperoxide Dismutaseglutamatemyricanol 11-sulfateMyrica rubramyricitrinneuroprotectionUPLC-Q-TOF-MS

Identifiers

PMID31426594
PMCPMC6720352
OpenAlexW2968464083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.